Credentiling Policy
Credentiling Policy
Credentiling Policy
CENTER
ARTICLE 1
DEFINITIONS
1.1. BYLAWS DEFINITIONS
The definitions contained in the Bylaws apply to this Policy unless specifically stated otherwise.
1.2. DEFINITIONS SPECIFIC TO THIS CREDENTIALING POLICY
These definitions apply to terms in this Credentialing Policy:
1.2.1. ACGME: Accreditation Council for Graduate Medical Education.
1.2.2. AOA: American Osteopathic Association.
1.2.3. APA: American Psychological Association.
1.2.4. APMA: American Podiatric Medical Association.
1.2.5. Board Certification: The process that a Physician, Dentist, Podiatrist, or Clinical
Psychologist begins after the completion of residency, fellowship, and/or other training that
when completed will lead to the granting of initial certification by one (1) of the following
Specialty Boards:
1.2.5.1. A member board of the American Board of medical specialists, also known as
“ABMS Member Board”.
1.2.5.2. An American osteopathic association AOA specialty certifying board certified
by the AOA Bureau of Osteopathic Specialists.
1.2.5.3. The American Board of Oral and Maxillofacial surgery
1.2.5.4. A Specialty Board, such as the American Board of Podiatric Surgery,
recognized by the Council on Podiatric Medical Education
1.2.5.5. A Specialty Board affiliated with the American Board of Professional
Psychology.
1.2.5.6. If the initial certification is time‐limited, the Maintenance of Certification
(“MOC”) process described by the Specialty Boards is included in this meaning.
Page 2 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
1.2.6. Board Certified: means an Applicant or Member has successfully completed the Board
Certification process, has a current and valid certificate, and is deemed to be Board Certified
by their respective Specialty Board(s). For time‐limited certifications, the Applicant or
Member must keep the certification current and valid through the MOC process to remain
Board Certified.
1.2.7. Board Eligible: means an Applicant or Member meets the qualifications to enter the
Board Certification process of their Specialty Board(s) and is recognized by their Specialty
Board(s) as being in the Board Certification process but is not currently Board Certified.
1.2.8. Board Eligibility Period: means the time frame that begins at the completion of residency,
fellowship, or other training and ends after the period of time allotted by each Applicant’s or
Member’s Specialty Board for Board Eligible practitioners to complete the initial Board
Certification process. This is typically five (5) to seven (7) years. If a Specialty Board does
not specify a maximum time for completion of the Board Certification process, then the time
will be considered seven (7) years after the completion of residency or fellowship.
1.2.9. CPME: means the Council on Podiatric Medical Education.
1.2.10. Locum Tenens: means temporary medical service.
1.2.11. Maintenance of Certification or MOC: means the continuous education, evaluation, and
improvement activities sponsored or required by a Specialty Board described in this
Policy’s definition of “Board Certification” to maintain Board Certification after initial
Board Certification.
ARTICLE 2
2. QUALIFICATIONS FOR MEMBERSHIP AND CLINICAL PRIVILEGES
Page 3 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 4 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
2.2.3.2. Oral and Maxillofacial Surgeons. Oral and Maxillofacial surgeons must have
completed a dental surgery training program accredited by the Commission on
Dental Accreditation of the American Dental Association.
2.2.3.3. Physicians (MD or DO). Physicians must have successfully completed a
residency accredited by the ACGME or the AOA in the specialty in which they are
seeking Clinical Privileges.
2.2.3.4. Podiatrists. Podiatrists must have successfully completed a two (2) year
surgical residency program accredited by the CPME.
2.2.3.5. Psychologists. Psychologists must have successfully completed an APA
approved doctoral degree program in psychology with at least three (3) years of post‐
doctoral experience in the practice of clinical psychology, or a two (2) year post‐
doctoral residency in Clinical Neuropsychology conforming to the Houston
Conference Guidelines for Advanced Training in Clinical Neuropsychology, or be
accredited by the American Psychological Association, or otherwise be qualified by
training and/or experience. Applicants must have a minimum of one (1) year
experience in an acute hospital setting, community mental health setting, and/or an
emergency room setting involving assessment for safety, especially suicidality and
homocidality.
2.2.3.6. Exemption from Residency Training Requirement for Legacy Members.
Medical Staff Members who have continuously held Clinical Privileges at this
Hospital without residency training certification since August 22, 2001, are
exempted from the residency‐training qualification for their area of practice.
2.2.3.7. Waiver of residency training qualification for Board‐certified individuals.
Applicants and Members who have obtained initial Board certification or who are
Board Eligible and within the Board Eligibility Period may apply for a waiver of the
Page 5 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 6 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 7 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 8 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
2.2.4.3.3. The time period allowed for the waiver will be determined on a case‐by‐
case basis. The maximum time allowed will not exceed twenty‐four (24)
months.
2.2.4.3.4. If Board Certification is not achieved within the time period allotted,
the Member’s Conditional Appointment and Conditional Privileges will
be Automatically Relinquished unless the Member requests and is granted
a leave of absence (“LOA) for the purpose of attaining Board Certification.
The maximum time period allowed for LOA to achieve Board Certification
will not exceed a total of twelve (12) months.
2.2.4.3.5. The granting of a waiver or a LOA in one case does not set a precedent for
any other case and is not intended to serve as a general exception to the
initial Board Certification requirement.
2.2.5. Geographical Location of Home and Practice. Each Applicant and Member requesting
Clinical Privileges will have his primary home and practice office close enough to the
Hospital Campus(es) at which they practice to meet their obligations for patient care and for
practitioner response and availability as detailed in the Rules and Regulations. The primary
home and practice office must be within a twenty‐five (25) mile radius of one of the
Campuses, unless an exception or waiver applies.
2.2.5.1. Exceptions to Geographical Location Requirements. The Geographical
Location Requirements do not apply to Honorary or Affiliate Members.
2.2.5.2. Waiver of Geographical Location Requirements. Members or Applicants
whose practice will not involve patient care obligations, who provides a unique or
important needed service on the Medical Staff, who only requests telemedicine
privileges, or who only exercises these patient care obligations when physically
present within the Hospital may petition for a waiver from the geographical
requirements.
Page 9 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
2.2.6. Cross‐Coverage for Illness and Unavailability. Each Member must at all times have
another qualified Member who is readily available and who has the necessary Clinical
Privileges to fulfill the duties and responsibilities of the Member as outlined in the
Bylaws, Medical Staff policies, and Rules and Regulations in the event of the individual's
illness or unavailability. Honorary and Affiliate Members are exempt from this cross‐
coverage requirement.
2.2.6.1. Subspecialists. In situations where a Member holds Clinical Privileges in a
Subspecialty in which only a limited number of practitioners in the community are
qualified for Clinical Privileges at the Hospital, but the Member’s Subspecialty
provides a unique or important needed service on the Medical Staff, the Board upon
recommendation of the Credentials Committee and MEC may approve a waiver of
the cross coverage requirement from the same Subspecialty if the intent of the
cross‐coverage requirement is satisfied from practitioners in similar specialties.
2.2.6.2. Failure to Provide Cross‐Coverage. Failure of a Member to arrange
cross‐coverage may result in the Automatic Relinquishment of the Member’s
appointment and Clinical Privileges.
2.2.7. Exclusion from Federally‐Funded Programs. Individuals excluded from federally‐funded
health care programs or included on the List of Excluded Individuals and Entities (LEIE) are
not eligible for appointment, reappointment, or Clinical Privileges.
2.2.8. Disclosure of Health Information. Each Applicant and Member seeking Clinical
Privileges must disclose health issues or conditions that could affect the individual’s ability
to exercise Clinical Privileges.
2.3. NO ENTITLEMENT TO APPOINTMENT
2.3.1. No individual will be entitled to appointment to the Medical Staff or to exercise particular
Clinical Privileges in the Hospital merely because he is licensed to practice a profession in
this or any other state; is a member of any particular professional organization; has had in
Page 10 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
the past or currently has Medical Staff appointment or Privileges at any hospital or other
health care facility; resides in the geographic service area of the Hospital; is affiliated with,
or under contract to, any managed care plan, insurance plan, HMO, PPO, or other entity; or
applies for any waiver to the qualifications for appointment or reappointment to the Medical
Staff.
2.4. NON‐DISCRIMINATION
2.4.1. No individual will be denied appointment, reappointment, or Clinical Privileges on the
basis of sex, race, creed, religion, color, national origin, sexual orientation, or on the basis of
any criteria unrelated to the delivery of quality patient care at the Hospital, professional
qualifications, or the Hospital’s purposes, needs and capabilities.
ARTICLE 3
3. CREDENTIALING PROCESS
3.1. APPLICATIONS: The MEC will recommend application forms to the Board for
approval. Currently, the Board has approved applications for:
3.1.1. Appointment
3.1.2. Reappointment
3.1.3. Reinstatement
3.1.4. Change of Medical Staff category
3.1.5. Grant of specific Clinical Privileges
3.1.6. leave of absence and reinstatement from a leave of absence
3.1.7. temporary privileges
3.1.8. disaster privileges
3.1.9. establishment of new categories of Clinical Privileges
The Credentials Committee has the authority to adopt corrections and clarifications to the
above Board‐approved forms that are, in the Committee’s judgment, technical
modifications, reorganization or renumbering, clarifications of previously approved
language, or corrections of punctuation, spelling, or other errors of grammar or expression.
Notice of such adopted corrections and clarifications must be given to the MEC and the
Board
Page 11 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 12 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
application and proceed to consider the Applicant. The Credentials Committee may
also recommend that a fine be levied for the violation of the Policy and as a
condition of granting Medical Staff membership.
3.3. DOCUMENTATION FOR APPLICATIONS: The following information, if applicable to
the particular application, will be required:
3.3.1. Authorizations. Any necessary electronic or written authorizations to allow third‐parties to
release any confidential information relevant to the request for membership or Clinical
Privileges.
3.3.2. Immunity and Release Forms. Agreements to extend immunity from liability and suit to the
fullest extent permitted by law to anyone who participates in the credentialing process,
including the Hospital, the Hospital’s employees, the Medical Staff and all other individuals
gathering information, providing information, or considering information.
3.3.3. References. Names and addresses of two (2) references as defined in the relevant
application. Additional references may be requested.
3.3.4. Medical Staff Appointments. List of previous Medical Staff appointments and a signed
release to allow other hospitals to disclose information about the Applicant’s or Member’s
current and previous Medical Staff appointment(s) or Clinical Privileges.
3.3.5. Ongoing/Additional Information. The following information must be provided as
part of an initial or reappointment application. Members and Applicants must notify the
Medical Staff Office within f iv e ( 5 ) B u s in es s D ay s if there are changes in this
information during the term of any appointment.
3.3.5.1. any administrative complaint issued by a professional licensing board or
governmental agency
3.3.5.2. any action by a professional licensing board or governmental agency that
resulted in the payment of any fine, formal discipline, educational requirements,
Page 13 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 14 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
3.3.6. Designation of Primary Campus. Applicants and Members will designate one Campus as
their Primary Campus. If requested by the President, the Credentials Committee
chairperson, a Clinical Department chairperson, or a Campus Chief of Staff, the Medical
Staff Office will provide a report of the Campus distribution of Member’s Patient Contacts.
Upon request by a Medical Staff Leader designated in this section, the Member’s Primary
Campus may be reassigned upon approval of the Credentials Committee and the MEC.
3.4. MEMBERSHIP PROCESS FOR APPLICATIONS FOR APPOINTMENT,
REAPPOINTMENT, REINSTATEMENT, CHANGE OF MEDICAL STAFF CATEGORY,
GRANTING SPECIFIC CLINICAL PRIVILEGES, OR FOR LEAVE OF ABSENCE
3.4.1. Initial Review. The Medical Staff Office will verify that the application is complete.
3.4.2. Report by Clinical Department Chairperson. Complete applications are transmitted to the
applicable Clinical Department chairperson for review. The Clinical Department chairperson
may request a personal interview with the Applicant or Member. The Clinical Department
chairperson will prepare a recommendation for action to be taken by the Credentials
Committee. The Clinical Department chairperson may designate the Clinical Department
vice chairperson, a Clinical Subspecialty chairperson, or a Campus Clinical Section
chairperson to assist with the Clinical Department level review.
3.4.3. Expedited Process for Conditional Membership and Conditional Privileges (Fast‐Track
Process).
3.4.3.1. After completion of the application and verification of the required elements by
the Medical Staff Office, an Applicant or Member may be granted Conditional
Appointment and Conditional Privileges prior to the meeting of the Credentials
Committee when the application documents the following:
3.4.3.1.1. consistent and successful residency training program record
3.4.3.1.2. no record of any disciplinary action or conditions during residency
training
Page 15 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 16 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
3.4.3.2.4. Once the above individuals have reviewed the application and have
approved the request for expedited Conditional Appointment and
Conditional Privileges, the Chief Medical Officer, the CEO, or their
designees will have the final authority to grant Conditional Appointment
and Conditional Privileges prior to a meeting of the Credentials
Committee, based on the application and submissions.
3.4.4. Consideration by the Credentials Committee. The Credentials Committee, or a
subcommittee formed for this purpose, will review the initial report of the Clinical
Department chairperson or designee, the completed application, and all supporting
materials, and then make a recommendation to the MEC. The Credentials Committee may
request a personal interview, and/or may refer an application to external reviewers or other
experts for additional recommendations. The Credentials Committee may modify
existing Conditional Privileges or may approve new Conditional Privileges pending
consideration by the MEC. If the recommendation of the Credentials Committee is delayed
longer than sixty (60) Business Days from the initial presentation of the application to the
Credentials Committee, then the Credentials Committee chairperson will give Notice to the
Candidate or Member explaining the reasons for the delay.
3.4.5. Actions and Recommendations by the MEC. The MEC will review the report and
recommendations of the Credentials Committee and may accept the recommendation, refer
the application back to the Credentials Committee for further review, or modify or reject the
recommendation and state specific reasons for disagreement with the recommendation of the
Credentials Committee.
3.4.5.1. If the recommendation is favorable, the Applicant may be awarded Conditional
Appointment and Conditional Privileges, if not yet granted, and the
recommendation will be forwarded to the Professional Affairs Committee for review.
Page 17 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 18 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
primary Clinical Department. The initial appointment period will not exceed thirty‐six (36)
months.
3.4.9. Leave of Absence. Members may be granted a Leave of Absence (“LOA”) according to the
following process:
3.4.9.1. A Member will request either a medical LOA (for example, physical illness or
condition, cognitive issue, mental disorder, alcohol and substance abuse disorder,
etc.) or a non‐medical LOA (for example, family obligation, pursuit of additional
education or training, preparation for board certification, military service, legal issue,
etc.). The application for LOA will state the reason(s) for the leave and will include
the beginning and ending dates of the requested leave.
3.4.9.2. The request for a LOA will be processed and reviewed in the same manner as
other applications for Members.
3.4.9.2.1. In addition to any other recommendations, the Clinical Department
chairperson or a designee will provide information to the Credentials
Committee on whether the Clinical Department chairperson believes that
granting the LOA will adversely affect the ability to provide emergency
call coverage.
3.4.9.2.2. The LOA may be denied, delayed, or modified to ensure that emergency
call coverage is not adversely affected.
3.4.9.2.3. For all applications for medical LOA, the Credentials Committee will
determine whether the Member will be referred for monitoring in
accordance with the Organizational Policy and, if applicable, the Impaired
Practitioner Policy.
3.4.9.3. A LOA will not exceed twelve (12) months. Absence by a Member for a
period of time in excess of the granted LOA will constitute voluntary resignation of
Medical Staff appointment and Clinical Privileges. An additional LOA may be
Page 19 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
requested but must be reviewed and approved according to the process outlined
herein and the total of all LOAs may not exceed twenty‐four (24) consecutive
months.
3.4.9.4. Reinstatement. A Member must request reinstatement of Clinical Privileges
by submission of the request to the Medical Staff Office within thirty 30) Business
Days from the expiration date of the LOA.
3.4.9.4.1. If the leave was a medical LOA and was referred to the PHAC for
monitoring, then the PHAC will provide a recommendation regarding
reinstatement to the Credentials Committee. If applicable, all conditions
for reinstatement imposed, including any conditions in the Impaired
Practitioner Policy, must be satisfied prior to consideration of the
reinstatement.
3.4.9.4.2. Change of Medical Staff Category. Members may request a change in their
Medical Staff category at any point during an appointment period. Any
emergency call assigned at the point the application is submitted to the
Medical Staff Office must be covered by the Member. The change in
category will not be in effect until processed and reviewed in the same
manner as outlined in this section.
3.5. DELINEATION OF CLINICAL PRIVILEGES
The Board will determine which categories and specific Clinical Privileges will be available for
application at the Hospital after considering the recommendations of the Medical Staff.
3.5.1. Process for Recommending Delineation of Clinical Privileges.
3.5.1.1. Clinical Department chairpersons and Clinical Subspecialty chairpersons will
propose the qualifications and the specific categories and descriptions of
Clinical Privileges for their respective Members. These recommendations will be
forwarded to the Credentials Committee and the MEC for consideration.
Page 20 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 21 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
forward these recommendations to the MEC, which will review the matter and forward
its recommendations to the Board for final action.
3.7. PROCESSES FOR GRANTING CLINICAL PRIVILEGES WITHOUT
MEMBERSHIP
3.7.1. Disaster Privileges (Emergency Clinical Privileges Under Disaster Conditions). Disaster
privileges may be granted to a health care professional when the emergency management
plan has been activated and the organization is unable to handle the immediate patient
needs. The emergency management plan will outline the requirements for such temporary
privileges. The CEO/Hospital Administrator/Incident Commander, with the concurrence of
the President or a designee and the appropriate Clinical Department chairperson or Disaster
Medical Director, will grant the emergency Clinical Privileges necessary, provided the
individual’s documentation is adequate and acceptable, and his identity confirmed.
3.7.2. Temporary and locum Tenens privileges. Applications may request temporary or locum
tenens. Clinical privileges without medical staff membership or more than 4 times per year.
3.7.2.1. Purpose of Granting. Temporary and locum tenens privileges are available.
Privileges may be granted for following reasons:
3.7.2.1.1. Proctors for Medical Staff Members. To provide observation to verify
competency in a procedure or technique that the Member was previously
trained to perform.
3.7.2.1.2. Preceptors for Medical Staff Members. To provide supervision and training
for a Member to learn a new procedure or technique.
3.7.2.1.3. Team Physicians. To provide medical services to athletes on sports teams
competing within the service area of the Hospital if the need arises for care
or treatment at the Hospital.
3.7.2.1.4. Important patient treatment Needs. To provide important patient care or
patient needs.
Page 22 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
3.7.2.2. Application Process. Each Applicant for temporary or locum tenens Clinical
Privileges without Medical Staff membership will complete the applicable
application form. The application and supporting documentation will be reviewed
by the following individuals who will verify that the information is complete and that
the criteria for granting temporary or locum tenens Clinical Privileges has been met:
3.7.2.2.1. Medical Staff Office
3.7.2.2.2. Department chairperson(s) or designee(s) in which the Clinical Privileges
are sought
3.7.2.2.3. Credentials chairperson or designee
3.7.2.2.4. President or designee
3.7.2.2.5. Chief Medical Officer or CEO, or designees
3.7.2.3. Approval of temporary clinical privileges. The chief medical officer, the CEO,
or designees will have the final authority to grant temporary or locum tenens clinical
privileges based on the application and submission.
3.7.2.4. Expiration of Temporary Privileges. The temporary Clinical Privileges
granted under this section will expire no later than eighty (80) Business Days one
hundred and twenty (120) days after being granted. Shorter expiration periods may
be used,
3.7.2.5. Expiration of locum tenens privileges. Locum tenens privileges granted under
this section will expire no later than 180 days after being granted. Shorter expiration
periods may be used, including but not limited to where the expiration date falls on a
non-business day.
3.7.2.6. Termination or temporary and Locum Tenens privileges. The president, chief
Medical officer, or CEO, or designees, will have the right to terminate temporary or
locum tenens clinical privileges at any time.
Page 23 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
4. ARTICLE
Page 24 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Members may be given the opportunity to voluntarily refrain from exercising Clinical Privileges
or taking other actions in cases where a precautionary suspension might be considered.
4.3.1. Documentation. The decision to voluntarily refrain from exercising Clinical Privileges or
from any other action must be documented by the Medical Staff Office and signed by the
Member. Voluntarily refraining from exercising Clinical Privileges will not be deemed to
be a surrender of Clinical Privileges nor a suspension of Clinical Privileges nor a waiver of
any rights to a hearing or appeal under the Bylaws.
4.3.2. Cooperation Does Not Preclude Immediate Action Under the Bylaws. The decision to
voluntarily refrain from exercising Clinical Privileges does not prevent any immediate
action from being taken, up to and including precautionary suspension.
4.3.3. Extends to Investigation. The Member may continue to voluntarily refrain from
exercising Clinical Privileges during any subsequent Investigation.
4.3.4. Duty to Notify the End of Cooperation. Members who voluntarily refrain from
exercising Clinical Privileges must notify the Medical Staff Office at least three (3)
Business Days before electing to resume the exercise of Clinical Privileges.
4.4. PROCEDURES FOR INVESTIGATIONS
4.4.1. Initiation. Both the MEC and the Board may initiate an Investigation of a Member.
The Administrative Subcommittee of the MEC may also initiate an Investigation between
meetings of the MEC.
4.4.2. Responsibility for Investigation. Once the determination has been made to begin an
Investigation, the MEC is responsible for investigating the concern and for making a
recommendation to the Board.
4.4.2.1. If the Board initiates the Investigation but the MEC fails to take any further
action to investigate or to make a recommendation back to the Board, then the Board
may appoint its own Investigative Committee to make a recommendation.
Page 25 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Page 26 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
4.4.5.3. External Reviewers. The Investigative Committee may request that the
Hospital retain an external reviewer to obtain testimony, written reports, or other
information from the reviewer pertinent to the issues being investigated.
4.4.5.4. Member’s Opportunity to Respond. Before the conclusion of the
Investigation, the Investigative Committee will give the Member an opportunity to
address the concern being investigated and offer information for the consideration
of the Investigation.
4.4.5.4.1. The opportunity to respond is not a hearing or appeal. There is no right to
have legal counsel or other personal representatives present during the
meeting.
4.4.5.4.2. The Member may be compelled to provide office medical records and
other information relevant to the case or cases under review and/or to
attend the Investigative Committee meeting if the Investigative
Committee requests the Members’ attendance.
4.4.5.5. Transcripts and Records. The Investigative Committee may keep transcripts of
witness statements and other records of the committee’s proceedings that it deems
necessary to document its report.
4.4.5.6. Attendance. The Investigative Committee may choose to meet even though not
all committee members can be present provided that the absent committee member
can review the transcripts and records of the meeting(s) at which he or she was not
present. All members must participate in the final deliberations of the Committee
that develops the recommendation to the MEC.
4.4.5.7. Investigative Committees will strive to complete their Investigation in a timely
manner.
4.4.5.8. If the Investigation continues for more than twenty (20) Business Days, the
Investigative Committee will make an interim report to the President prior to each
Page 27 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
MEC meeting. The interim report to the President will include any items needed by
the Investigative Committee.
4.4.5.9. At the conclusion of the Investigation, the Investigative Committee will report
to the MEC regarding the outcome of the Investigation, pertinent facts, and
recommendations including but not limited to the following:
4.4.5.9.1. no action
4.4.5.9.2. a letter of counsel or reprimand
4.4.5.9.3. imposition of a fine
4.4.5.9.4. additional education or training,
4.4.5.9.5. reduction or suspension of Clinical Privileges
4.4.5.9.6. imposition of conditions for continued appointment including but not
limited to monitoring or mandatory consultation
4.4.5.9.7. revocation of Medical Staff appointment and Clinical Privileges
4.4.5.10. The MEC will consider the information and the report and make its own
recommendation regarding the Member’s Clinical Privileges and membership to the
Board.
4.4.5.11. If the recommendation of the MEC is an adverse recommendation that
would entitle the Member to a hearing under the Bylaws, the Bylaws procedure for a
hearing and any subsequent proceedings will apply.
5. ARTICLE
Page 28 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
5.1.2. This article does not alter any requirement under the Bylaws to give Notice of an
adverse recommendation that would entitle the Applicant or Member to a hearing.
5.2. TIMING OF NOTICES
5.2.1. Granting of Conditional Privileges Pending Board Approval. Applicants and Members
will be given Notice within two (2) Business Days if they are approved for Conditional
Privileges.
5.2.2. Other Notices from the Medical Staff to Members and Applicants. Other Notices of
credentialing requests or actions may be given as soon as practical.
5.3. CONTENT OF NOTICES
Notices will include the name of the individual or Committee taking the action, the action taken
or recommendation made, and, in the case of Privileges, a delineation of the Clinical Privileges
that will be affected. If Information is requested, a list of the information requested will be kept
in electronic or written form in the Applicant’s or Member’s credentialing file.
5.4. EFFECT OF FAILURE TO FOLLOW NOTICE PROVISIONS
5.4.1. The failure to provide Notice in the format or within the time frames set forth in this
Policy will not be the basis to invalidate any action taken by the Hospital, its employees,
or its Medical Staff.
APPROVALS:
Page 29 | 30
PAKISTAN KIDNEY AND LIVER INSTITUTE AND
RESEARCH CENTER
Department Name: Medical Staff Affairs Document Number:
Title of the Policy & Procedure: Medical Staff Credentialing Version Number: 01
Policy
Effective Date:
Prepared by:
Signature &
Employee ID
Name Title Date
Reviewed by:
Signature &
Employee ID
Name Title Date
Authorized by:
Signature &
Employee ID
Name Title Date
Page 30 | 30